Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus J Couch

Showing results (461-470 of 544) with videos related to

Pageof 55
Sort By:
Plos One|November 13, 2014
MicroRNA related polymorphisms and breast cancer riskSofia Khan, Dario Greco, Kyriaki Michailidou, et al.
Human Molecular Genetics|June 15, 2014
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeKristen S Purrington, Seth Slettedahl, Manjeet K Bolla, et al.
Human Molecular Genetics|May 21, 2011
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumAnnegien Broeks, Marjanka K Schmidt, Mark E Sherman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
Cancer Research|February 15, 2012
19p13.1 is a triple-negative-specific breast cancer susceptibility locusKristen N Stevens, Zachary Fredericksen, Celine M Vachon, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Cancer Research|July 29, 2018
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskYingchang Lu, Alicia Beeghly-Fadiel, Lang Wu, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Pageof 55

Showing results (461-470 of 544) with videos related to

Sort By:
Pageof 55
Plos One|November 13, 2014
MicroRNA related polymorphisms and breast cancer riskSofia Khan, Dario Greco, Kyriaki Michailidou, et al.
Human Molecular Genetics|June 15, 2014
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeKristen S Purrington, Seth Slettedahl, Manjeet K Bolla, et al.
Human Molecular Genetics|May 21, 2011
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumAnnegien Broeks, Marjanka K Schmidt, Mark E Sherman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
Cancer Research|February 15, 2012
19p13.1 is a triple-negative-specific breast cancer susceptibility locusKristen N Stevens, Zachary Fredericksen, Celine M Vachon, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Cancer Research|July 29, 2018
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskYingchang Lu, Alicia Beeghly-Fadiel, Lang Wu, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Pageof 55